TP53 and neuroblastoma: Almac4 treatment caused a significant reduction in p53 protein K48-ubiquitination in NB cells, suggesting that endogenous ubiquitin ligase activity was not sufficient to overcome USP7 inhibition by Almac4 (Figure 4H).